[論文摘要] Low-Dose (30 mCi) Radioactive Iodine Therapy in the Patients With Differentiated Thyroid Cancer: VGHKS Experience
YL Chiu, NJ Peng - 核子醫學暨分子影像雜誌, 2019 - airitilibrary.com
… on Cancer (AJCC) tumor size, lymph node, metastasis (TNM) stage at initial diagnosis; (2)
RAI dosage and times; (3) decision making to … factor to affect decision making. Other factors …
RAI dosage and times; (3) decision making to … factor to affect decision making. Other factors …
人工智能在甲状腺癌精准化诊疗中的研究进展
李铃睿, 杜博, 陈创 - 中国肿瘤临床, 2020 - cjco.cn
… decision-making. This review focuses on the use of AI to evaluate and predict the prognosis
of thyroid cancer … in the thyroid cancer. Second, the potential applications of AI in diagnosing …
of thyroid cancer … in the thyroid cancer. Second, the potential applications of AI in diagnosing …
淋巴细胞相关炎症指数预测甲状腺癌预后研究进展
李灿晓, 梁楠, 李世杰, 孙辉 - 中国实用外科杂志, 2021 - zgsyz.com
… the treatment of radioiodine refractory differentiated thyroid cancer patients (RAIR DTC); …
clinical decision-making of PTC patients;The study of PLR and the prognosis of thyroid cancer …
clinical decision-making of PTC patients;The study of PLR and the prognosis of thyroid cancer …
2023 年版《 Bethesda 甲状腺细胞学分类诊断系统》 更新要点及解读
张福荣, 赵萩阳, 黄韬 - 中国实用外科杂志, 2024 - zgsyz.com
… efficacy of thyroid cancer, its application in the diagnosis and treatment of thyroid cancer
is gradually expanding, with some instances even influencing surgical decision-making. …
is gradually expanding, with some instances even influencing surgical decision-making. …
放射性碘治疗在儿童分化型甲状腺癌中应用
宋娟娟, 林岩松 - 中国实用外科杂志, 2022 - zgsyz.com
… therapy for children differentiated thyroid cancer … decision making for cDTC. The above
advancements are expected to provide basis for individualized assessment and decision making …
advancements are expected to provide basis for individualized assessment and decision making …
局部进展期甲状腺癌预后评价
张浩, 常煜昂 - 中国实用外科杂志, 2023 - zgsyz.com
… thyroid cancer (LATC) is one of the leading causes of death and postoperative recurrence in
thyroid cancer … LATC are TNM staging and American Thyroid Society (ATA) risk stratification …
thyroid cancer … LATC are TNM staging and American Thyroid Society (ATA) risk stratification …
甲状腺癌远处转移的多学科诊治
张浩, 孙煜博 - 中国实用外科杂志, 2024 - zgsyz.com
… Abstract: Multidisciplinary diagnosis and treatment of distant metastases in thyroid cancer …
Department of Thyroid Surgery, the First Hospital of China Medical University, Shenyang …
Department of Thyroid Surgery, the First Hospital of China Medical University, Shenyang …
[HTML][HTML] 645 例初治甲状腺乳头状癌患者气管周围淋巴结转移的危险因素分析
辅容, 陆辉, 杭菁, 施杲旸 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
… with thyroid nodules and differentiated thyroid cancer:what is new and what has changed?[J].…
Predic⁃ tive value of the Delphian and level VI nodes in papillary thyroid cancer[J].ANZ J …
Predic⁃ tive value of the Delphian and level VI nodes in papillary thyroid cancer[J].ANZ J …
131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义
赵腾, 梁军, 林岩松 - 国际放射医学核医学杂志, 2015 - ijrmnm.com
… <,’E2P5.8;"3;’ "8+/,$*7,] Serum thyroglobulin#Tg$ is an important modality in the long term
follow"up of patients with differentiated thyroid cancer#DTC$. Measurements of serum Tg …
follow"up of patients with differentiated thyroid cancer#DTC$. Measurements of serum Tg …